Pages that link to "Q33578333"

The following pages link to Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia (Q33578333):

Displaying 13 items.

• Philadelphia chromosome-like acute lymphoblastic leukemia (Q43431904) (← links)
• Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome (Q45233800) (← links)
• The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia. (Q53703572) (← links)
• SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia. (Q55273917) (← links)
• Advances in biology of acute lymphoblastic leukemia (ALL) and therapeutic implications (Q61449792) (← links)
• Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group (Q89574586) (← links)
• Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population (Q89768692) (← links)
• BCR/ABL1-like acute lymphoblastic leukemia: How to diagnose and treat? (Q90611076) (← links)
• Constitutive activation of RAS/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in Down syndrome B-cell leukemia (Q90710875) (← links)
• SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain (Q91997647) (← links)
• GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemia (Q92290306) (← links)
• Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia (Q92627035) (← links)
• Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia (Q93382206) (← links)